Swissmedic
REGULATORY UPDATE
swissdamed: As of 1 July 2026, mandatory registration applies to medical devices and in vitro diagnostic medical devices
Published: 7/1/2026Detected: 7/1/2026
Summary preview
Establishes that, from 1 July 2026, mandatory registration requirements apply to both medical devices and in vitro diagnostic medical devices under swissdamed.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#swissdamed
#mandatory registration
#medical devices
#in vitro diagnostic medical devices
#compliance
Official Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026
- Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances10/1/2026
- Revision of the Guidance document Authorisation Biosimilar10/1/2026
- Swissmedic Portal Release – New Features Available from 23 September 20269/24/2026
- I-SMI.TI.22e Notifications according to Article 41, MPLO9/23/2026